https://www.selleckchem.com/pr....oducts/Floxuridine.h
The use of VA-ECMO for patients with cardiac arrest or cardiogenic shock in the cardiac catheterization laboratory may be associated with improved survival. Clinicians should be aware of a high complication rate of this therapy. Further data is needed to best select the appropriate form of mechanical circulatory support in this clinical context.Differential outcomes based on target vessel diameter persist in the era of second generation drug eluting stents. These differences are mainly driven by need for target vessel revascularizat
Curtir
Comentario
Compartilhar
